AnodyneWiki

Methyltestosterone

Methyltestosterone
Methyltestosterone
Molecular structure drawn from PubChem coordinates
Rotamer
[]
Conformer structure via 3Dmol.js
Enable javascript to view conformer structure via 3Dmol.js
Physical properties
[]
Molecular mass302.50 g/mol [1]
AppearanceCrystals from hexane [1]
OdorOdorless [1]
Melting point163 °C [1]
Solubility33.9 mg/L (at 25 °C) [1]
Predicted LogP3.4 [1]
Structural Identifiers
[]
Molecular formulaC20H30O2
IUPAC name(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
SMILESC[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C
InChIInChI=1S/C20H30O2/c1-18-9-6-14(21)12-13(18)4-5-15-16(18)7-10-19(2)17(15)8-11-20(19,3)22/h12,15-17,22H,4-11H2,1-3H3/t15-,16+,17+,18+,19+,20+/m1/s1
InChIKeyGCKMFJBGXUYNAG-HLXURNFRSA-N
CAS number58-18-4
UNIIV9EFU16ZIF
PubChem CID6010
Pharmacokinetics[]
Elimination half-life150 minutes (~2.5–3 hours)[3]
Duration of action1–3 days
MetabolismLiver
ExcretionUrine: 90%, Feces: 6%
Routes of administrationBy mouth, buccal, sublingual
Toxicity
[]
Mouse:
- ip: 430 mg/kg
 [1]

Methyltestosterone (also known as 17-Methyltestosterone, Metandren, Testred, Android, Androsten, 17α-Methyltestosterone, Dumogran, Malestrone, Masenone or Mastestona) is a hormone and steroid substance of the steroid class.

Chemistry

 []

Methyltestosterone is a single defined stereoisomer.

Methyltestosterone matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

The effects of testosterone in humans and other vertebrates occur by way of two main mechanisms: by activation of the androgen receptor (directly or as DHT), and by conversion to estradiol and activation of certain estrogen receptors. Free testosterone (T) is transported into the cytoplasm of target tissue cells, where it can bind to the androgen receptor, or can be reduced to 5α-dihydrotestosterone (DHT) by the cytoplasmic enzyme 5α-reductase. DHT binds to the same androgen receptor even more strongly than T, so that its androgenic potency is about 2.5 times that of T. The T-receptor or DHT-receptor complex undergoes a structural change that allows it to move into the cell nucleus and bind directly to specific nucleotide sequences of the chromosomal DNA. The areas of binding are called hormone response elements (HREs), and influence transcriptional activity of certain genes, producing the androgen effects. [1]

Medical side effects []

25 side effects listed on drug labels in (methyltestosterone).

  • Alopecia
  • Amenorrhoea
  • Anxiety
  • Coagulopathy
  • Libido decreased
  • Disturbance in sexual arousal
  • Gynaecomastia
  • Headache
  • Haemorrhage
  • Haemoglobin
  • Hirsutism
  • Jaundice cholestatic
  • Nausea
  • Azoospermia
  • Peliosis hepatis
  • Polycythaemia
  • Angiopathy
  • Virilism
  • Paraesthesia
  • Enlarged clitoris
  • Menstruation irregular
  • Anaphylactic shock
  • Anaphylactoid reaction
  • Blood cholesterol increased
  • Embolism venous

Indications

  • Breast cancer
  • Cryptorchism
  • Delayed puberty
  • Hypogonadism male
  • Neoplasm
  • Orchitis
  • Primary hypogonadism
  • Puberty
  • Secondary hypogonadism
  • Testosterone deficiency
  • Trauma

 []

  • Brazil: Methyltestosterone is a C5.[4]
  • Canada: Methyltestosterone is a Schedule IV.
  • United States: Methyltestosterone is a Schedule III under the "Controlled Substances Act".
  • Australia: Methyltestosterone is a Schedule 4.
  • Other: Methyltestosterone is a Rx-only.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 6010, Methyltestosterone. Accessed November 22, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/6010
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Methyltestosterone. UNII: V9EFU16ZIF. Global Substance Registration System. Accessed November 22, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/V9EFU16ZIF
  3. Behre HM, Wang C, Handelsman DJ, Nieschlag E. Testosterone. 2004. https://doi.org/10.1017/CBO9780511545221.015
  4. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 04:51:38
drugspromissing (no DrugsPRO reagent data)2026-11-20 04:51:34
erowidmissing (no Erowid substance of that name)2026-11-20 04:51:34
gsrsok2026-11-20 04:51:35
hmdbmissing (hmdb.ca refused automated access to HMDB0015655)2026-11-20 04:51:34
keggok2026-11-20 04:51:36
pubchemok2026-11-20 04:51:34
redditmissing (no r/tripreports posts mention it)2026-11-20 04:51:34
siderok2026-11-20 04:51:34
structureok2026-11-20 04:51:34
wikipediaok2026-11-20 04:51:34